ACRV 8-K: SEC filing

Acrivon Therapeutics

Filed with the SEC on · accession 0001193125-26-470245

ACRV filed a 8-K (current report) with the SEC on Nov 20, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -14.6% by the first close after the filing.

Summary of the filing

Acrivon Therapeutics announced that late-breaker oral plenary results from the dose escalation phase of its ACR-2316 Phase 1/2 trial were presented at the 38th EORTC-NCI-AACR Symposium, with the presentation deck furnished via an 8-K.

Key details

RegistrantAcrivon Therapeutics, Inc.
Presenter institutionThe University of Texas MD Anderson Cancer Center
Presenter, the university of texas md anderson cancer centerTimothy A. Yap
President and chief executive officerPeter Blume-Jensen

How ACRV stock reacted

Close before

$1.40

Nov 19, 2026

First close after

-14.64%

$1.20

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ACRV, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ACRV?

Click here

Frequently asked questions

What did ACRV file with the SEC on Nov 20, 2026?

ACRV filed a 8-K (SEC filing). Acrivon Therapeutics announced that late-breaker oral plenary results from the dose escalation phase of its ACR-2316 Phase 1/2 trial were presented at the 38th EORTC-NCI-AACR Symposium, with the presentation deck furnished via an 8-K.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did ACRV stock react to this filing?

ACRV closed at $1.40 before the filing and $1.20 on Nov 20, 2026 (-14.64%).

Other ACRV SEC filings

Get alerts when ACRV files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days